Find and Pitch Jounalists, Get Your Story Covered

Tags: Bispecific Antibodies cytokine release syndrome immune effector cell–associated neurotoxicity syndrome Bispecific Treatments Diffuse Large B Cell Lymphoma

	Profile	Recent Articles on Subject
1	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Two Investigational Treatments for ALS Show Glimmer of Hope - 6 days ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors - 18 days ago FDA Approves Zanidatamab for Biliary Tract Cancer - 3 months ago Year in Review: Follicular Lymphoma - about 1 year ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - over 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: Johnson & Johnson says its lung cancer drug significantly extended survival - about 2 months ago STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 2 months ago
4	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final Recommendations - about 2 months ago Administering Bispecifics in the Community vs Academic Centers - about 2 months ago Resources and Education for Operationalizing Bispecifics - 3 months ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 3 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 3 months ago Current Landscape of Bispecific Therapies for RRMM - 3 months ago Alternative Treatments for eBC and mBC - 9 months ago Considerations for Maintenance Therapy in the Community Oncology Setting - 9 months ago
5	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies - about 2 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Investigators Develop Training Tool to Improve Prescriber-Patient Communication About Biosimilars - 2 months ago FDA Grants Breakthrough Therapy Designation for Nipocalimab to Treat Sjögren Disease - 3 months ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 6 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 8 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 12 months ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - about 1 year ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - about 1 year ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - over 1 year ago Key Market Trends for the Current Specialty Drug Pipeline - over 1 year ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 3 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 11 months ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 4 months ago Addressing Challenges When Implementing Bispecific Antibodies in Diverse Settings - 8 months ago Addressing the Challenges of Implementing Bispecific Antibodies in Health Care Centers - 11 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 11 months ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 11 months ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - 6 months ago
10	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis - 11 months ago

Journalists covering Bispecific Treatments